BIOPHAN RESTRUCTURES BOARD IN CONNECTION WITH APPLICATION FOR LISTING ON NATIONAL EXCHANGE

Biophan Technologies, Inc., a developer of next-generation medical technology, today announced that it is reducing the size of its board of directors from 7 to 5 members in order to have a majority of independent directors to satisfy one of the qualifications for listing on a major national stock exchange. Genetic Engineering News (http://www.genengnews.com/news/bnitem.aspx?name=2554236)